JP4283892B2 - 生物学的活性を有する組成物 - Google Patents

生物学的活性を有する組成物 Download PDF

Info

Publication number
JP4283892B2
JP4283892B2 JP53881597A JP53881597A JP4283892B2 JP 4283892 B2 JP4283892 B2 JP 4283892B2 JP 53881597 A JP53881597 A JP 53881597A JP 53881597 A JP53881597 A JP 53881597A JP 4283892 B2 JP4283892 B2 JP 4283892B2
Authority
JP
Japan
Prior art keywords
composition
weight
glycol
solvent
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP53881597A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000509385A (ja
JP2000509385A5 (cg-RX-API-DMAC10.html
Inventor
リンダール,オーケ
ブリランド,リカード
Original Assignee
ヤゴテック・アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヤゴテック・アーゲー filed Critical ヤゴテック・アーゲー
Publication of JP2000509385A publication Critical patent/JP2000509385A/ja
Publication of JP2000509385A5 publication Critical patent/JP2000509385A5/ja
Application granted granted Critical
Publication of JP4283892B2 publication Critical patent/JP4283892B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP53881597A 1996-04-30 1997-04-29 生物学的活性を有する組成物 Expired - Fee Related JP4283892B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9601665A SE9601665D0 (sv) 1996-04-30 1996-04-30 Biologically active composition
SE9601665-4 1996-04-30
PCT/SE1997/000721 WO1997040818A1 (en) 1996-04-30 1997-04-29 Biologically active composition

Publications (3)

Publication Number Publication Date
JP2000509385A JP2000509385A (ja) 2000-07-25
JP2000509385A5 JP2000509385A5 (cg-RX-API-DMAC10.html) 2004-12-09
JP4283892B2 true JP4283892B2 (ja) 2009-06-24

Family

ID=20402417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53881597A Expired - Fee Related JP4283892B2 (ja) 1996-04-30 1997-04-29 生物学的活性を有する組成物

Country Status (12)

Country Link
US (1) US6979454B1 (cg-RX-API-DMAC10.html)
EP (1) EP0952819B1 (cg-RX-API-DMAC10.html)
JP (1) JP4283892B2 (cg-RX-API-DMAC10.html)
AT (1) ATE345777T1 (cg-RX-API-DMAC10.html)
AU (1) AU701720B2 (cg-RX-API-DMAC10.html)
CA (1) CA2251702C (cg-RX-API-DMAC10.html)
DE (1) DE69736985T2 (cg-RX-API-DMAC10.html)
ES (1) ES2276425T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ332497A (cg-RX-API-DMAC10.html)
SE (1) SE9601665D0 (cg-RX-API-DMAC10.html)
WO (1) WO1997040818A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA973705B (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
DK1871353T3 (da) * 2005-04-15 2011-04-04 Einstein Coll Med Vitamin k til forebyggelse eller behandling af hududslæt sekundært til anti-EGFR-terapi
US9428582B2 (en) * 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
ES2550481T3 (es) * 2007-08-16 2015-11-10 The University Of Chicago Resistencia a patógenos de plantas
US8815953B2 (en) * 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
CA2738970A1 (en) * 2008-10-31 2010-05-06 Moberg Derma Ab Topical composition comprising a combination of at least two penetration enhancing agents
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299828A (en) * 1979-05-31 1981-11-10 E. R. Squibb & Sons, Inc. Corticosteroid stick formulations
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
ATE107517T1 (de) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.

Also Published As

Publication number Publication date
NZ332497A (en) 1999-05-28
SE9601665D0 (sv) 1996-04-30
ATE345777T1 (de) 2006-12-15
CA2251702A1 (en) 1997-11-06
AU701720B2 (en) 1999-02-04
AU2796997A (en) 1997-11-19
ES2276425T3 (es) 2007-06-16
JP2000509385A (ja) 2000-07-25
DE69736985T2 (de) 2007-09-20
CA2251702C (en) 2007-01-09
ZA973705B (en) 1997-11-25
US6979454B1 (en) 2005-12-27
EP0952819B1 (en) 2006-11-22
WO1997040818A1 (en) 1997-11-06
EP0952819A1 (en) 1999-11-03
DE69736985D1 (de) 2007-01-04

Similar Documents

Publication Publication Date Title
JP7622218B2 (ja) 円形脱毛症治療用の複方外用製剤及びその製造方法
US5061700A (en) Glyceryl acetate ointment vehicles
TWI527597B (zh) 局部組成物
US5104656A (en) Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent
US4310516A (en) Cosmetic and pharmaceutical vehicle thickened with solid emulsifier
EP2961380B1 (en) Injectable long-acting local anesthetic semi-solid formulations and its compositions
AU9002601A (en) Novel topical oestroprogestational compositions with systemic effect
JPH05310591A (ja) シクロスポリン含有外用薬剤
JPH02191214A (ja) 医薬活性剤の経皮デリバリー用組成物
PL189358B1 (pl) Kompozycja farmaceutyczna do podawania doustnego
JP7268132B2 (ja) 局所用組成物
AU701720B2 (en) Biologically active composition
JP2015227354A (ja) モメタゾンとプロピレングリコールとの水中油型エマルジョン
KR100623534B1 (ko) 피부 침투제를 포함하는 국소용 제제 및 그의 용도
JP3593716B2 (ja) 痔疾治療用組成物
US11426418B2 (en) Injectable long-acting semi-solid gel formulations
RU2040252C1 (ru) Ранозаживляющее средство
JPS6218526B2 (cg-RX-API-DMAC10.html)
WO1994026234A1 (en) Water-in-oil emulsion compositions
CN113262302B (zh) 可注射长效半固体凝胶制剂
JP2005008599A (ja) 局所麻酔組成物
JPH06271420A (ja) 化粧料または皮膚外用剤の吸水性改善剤
JPH10330250A (ja) メナテトレノン油性製剤
JP5105663B2 (ja) 塩化リゾチームを含む粘性化粧料又は薬剤の製造方法並びに塩化リゾチームを含む粘性化粧料又は薬剤
JPH06287137A (ja) スルホニウム化合物含有皮膚外用剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040415

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040415

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071113

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080213

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080324

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080701

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081001

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081226

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090224

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090323

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120327

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130327

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130327

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140327

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees